期刊文献+

影响血清地高辛浓度因素的调查分析 被引量:10

Investigation and analysis of factors affecting on serum-digoxin concentration
原文传递
导出
摘要 目的:探讨我院应用地高辛的现状及影响血清地高辛浓度的因素。方法:收集2005年我院861例次血清地高辛浓度数据,并采用多元回归方法分析血清地高辛浓度和年龄、性别、血清肌酐浓度、剂量等因素的关系。结果:年龄(age)、性别(sex)、血清肌酐浓度(Scr)及剂量(dose)等4因素均对血清地高辛浓度(con)有影响(P<0.05),经多元回归分析它们的关系可以表达为:con=-0.474+0.750×dose+0.154×Scr+0.128×sex+0.003×age。结论:血清地高辛浓度个体差异较大,影响血清地高辛浓度有多种因素。对于大多数患者服用地高辛的剂量不宜>0.125mg/d,如果血清肌酐值偏高,提示患者可能有肾功能减退,应该减量服用地高辛。对于女性患者更应该仔细调整剂量,以免出现地高辛中毒。 Objective. To investigate and analyse the situation of digoxin used in our hospital and the factors affecting on serum-digoxin concentration. Methods: Eight hundred and sixty-one data of serum-digoxin concentration were collected in our hospital in 2005. The relationship between serum-digoxin concentration and the factors including age ,sex, serum-creatine concentration was analysed by multivariate regression analysis. Results: The serum-digoxin concentration was affected by the four factors of age, sex, serum- creatine concentration, and the dose (P≤ 0.05). The relationship between them were con= -0.474+0.750×dose+0.154× Scr+0.128×sex+0.003×age by multivariate regression analysis. Conclusion: Serum-digoxin concentration varies with individuals and is affected by many factors. As regards most patients, the dose ofdigoxin should not be over 0.125 mg daily. If the serum-creatine concentration exceed the normal range, it is likely to be renal dysfunction to the patient. In such a case, the dose of digoxin should be reduced. As regards women, the dose of digoxin should be carefully adjusted to avoid digoxin toxicity.
出处 《药物不良反应杂志》 2006年第5期342-346,共5页 Adverse Drug Reactions Journal
关键词 地高辛 血药浓度 监测 digoxin drug blood concentration monitoring
  • 相关文献

参考文献14

  • 1The Digitalis Investigation Group (DIG) . The effect of digoxin on mortality and morbidity in patients with heart failure[J]. N Engl J Med, 1997, 336(8): 525-535.
  • 2Hood WB, Dans AL Guyatt GH, et al. Digitalis for treatmerit of congestive heart failure in patients in sinus rhythm [J]. Cochrane Database Syst Rev, 2004, (2):CD002901.
  • 3Saif S, Jeptha P, Yongfei Wang, et al. Association of serum digoxin concentration and outcomes in patients with heart failure[J]. JAMA, 2003, 289(7): 871-877.
  • 4Aronow WS. Treatment of systolic and diastolic heart failure in the elderly[J]. Am Med Dir Assoc, 2006, 7(1):63-64.
  • 5Rathore SS, Wang Y, Krtmtholz HM. Sex-based differences in the effect of digoxin for the treatment of heartfailure. [J]. N Engl J Med, 2002, 347(18): 1403-1411.
  • 6Shlipak MG, Smith GL, Rathore SS, et al. Renal function, digoxin therapy, and heart failure outcomes:evidence from the digoxin intervention group trial [J].Am Soc Nephrol, 2004, 15(8): 2195-2203.
  • 7Rich MW, McSherry F, Williford WO, et al. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study[J]. Am Coll Cardiol, 2001, 38(3): 806-813.
  • 8Slatton ML, Irani WN, Hall SA, et al. Dose digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure in normal sinus rhythm. [J]. Am J Coll Cardiol, 1997,29: 1206.
  • 9李景苏,蔡长春,侯艳宁.地高辛给药方案与血药浓度及临床疗效的关系[J].临床误诊误治,2006,19(1):3-5. 被引量:17
  • 10Misiaszek B, Heckman GA, Merali F, et al. Digoxin prescribing for heart failure in elderly residents of long-term care facilities[J]. Can J Cardiol, 2005, 21(3): 281-286.

二级参考文献7

共引文献16

同被引文献88

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部